《大行》摩通升港交所(00388.HK)目標價至500元 上調評級至「增持」
摩根大通發表研究報告指,港交所(00388.HK)的日均交易量持續在高位橫行,相信是受到資金流動、南向通、IPO及A股市場改善等影響。該行表示,基於預期港交所更高的日均交易量預測,預計2025至27財年分別達2,350億、2,500億及2,520億元,將其每股盈測相應上調5%至16%。
摩通表示,市場對港交所中期前景的可見性通常會導致PE倍數的重估,因此將目標價由400元上調至500元,評級由「中性」升至「增持」。另外,該行預計,港交所上半年利潤為49.3億元,即次季為23.99億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.